Ftse Mib
35.108,51
0,00%
DAX
20.289,30
-0,14%
S&P 500
5.918,25
0,16%
NASDAQ
19.478,88
-0,06%
Bitcoin
93.561,56
-1,57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire ETFs Regno Unito LSE Ls 2x Salesforc (CRME) Ls 2x Salesforc (CRME) Notizie

CRME

Ls 2x Salesforc (CRME)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:CRME
DataOraFonteTitoloSimboloCompagnia
24/04/202316:47UK RegulatoryLeverage Shares PLC Issuer Call Redemption ConfirmationLSE:CRMELs 2x Salesforc
21/12/200923:05PR Newswire (US)Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase PlansLSE:CRME
18/12/200900:00PR Newswire (US)Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator StudyLSE:CRME
09/11/200914:40PR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
07/11/200900:00PR Newswire (US)Cardiome to Release Third Quarter ResultsLSE:CRME
02/11/200920:35PR Newswire (US)Cardiome To Present At Oppenheimer Healthcare ConferenceLSE:CRME
28/10/200921:58PR Newswire (US)Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 TrialLSE:CRME
17/10/200902:54PR Newswire (US)Cardiome Pharma Corp. Announces Final Results of Tender OfferLSE:CRME
14/10/200912:00PR Newswire (US)Cardiome Pharma Corp. Announces Preliminary Results of Tender OfferLSE:CRME
01/09/200920:57PR Newswire (US)Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender OfferLSE:CRME
28/08/200919:30PR Newswire (US)Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of LSE:CRME
25/08/200923:11PR Newswire (US)Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common SharesLSE:CRME
11/08/200913:45PR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
11/08/200901:45PR Newswire (US)Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol AgreementLSE:CRME
10/08/200922:35PR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
03/08/200923:16PR Newswire (US)Cardiome Announces Management TransitionLSE:CRME
28/07/200917:45PR Newswire (US)Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.LSE:CRME
19/05/200914:30PR Newswire (US)Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now EffectiveLSE:CRME
15/05/200922:05PR Newswire (US)Cardiome Reports First Quarter ResultsLSE:CRME
28/11/200823:31PR Newswire (US)Cardiome Discloses Chairman And CEO's Involuntary Share SaleLSE:CRME
24/10/200804:40PR Newswire (US)Cardiome Announces Filing Of Shelf Registration StatementLSE:CRME
09/10/200818:20PR Newswire (US)Cardiome Provides Regulatory UpdateLSE:CRME
11/08/200822:30PR Newswire (US)Cardiome to Release Second Quarter Results and Hold Conference CallLSE:CRME
11/08/200815:18PR Newswire (US)Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)LSE:CRME
23/07/200820:10PR Newswire (US)Cardiome Announces Preferred Share FinancingLSE:CRME
14/07/200814:25PR Newswire (US)Cardiome Announces Positive Phase 2b Results For Oral VernakalantLSE:CRME
13/07/200818:00PR Newswire (US)Cardiome To Hold Conference CallLSE:CRME
03/06/200811:32PR Newswire (US)K I L L K I L L K I L L -- Cardiome Pharma Corp.LSE:CRME
28/05/200822:25PR Newswire (US)TEST - Jay 14 - Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as StrategicLSE:CRME
12/05/200823:45PR Newswire (US)Cardiome To Release 2008 First Quarter ResultsLSE:CRME
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:CRME

La tua Cronologia

BIT
I10642
IT0005626343 20251201 34
BIT
X42685
Natixis
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network